Health ยท DR Congo
Ebola Deaths Reach 5,376 as Africa CDC Reports More Than 10,400 Cases
Africa CDC data show the Bundibugyo-strain Ebola outbreak has killed 5,376 people, almost all in DR Congo, with about 10,444 infections across DR Congo, Uganda and Kenya. The strain has a fatality rate above 50 percent and has no approved vaccine or treatment, though Ervebo trials have begun.
The death toll from the latest Ebola outbreak in Africa has risen to 5,376, with the Democratic Republic of the Congo accounting for nearly all fatalities, according to figures released by the Africa Centres for Disease Control and Prevention (Africa CDC) on Monday.
The agency said 5,372 of the deaths were recorded in the DRC, with two each in Kenya and Uganda. The Bundibugyo strain of the virus, which is driving the outbreak, has infected about 10,444 people across the three countries, with a fatality rate above 50 percent.
The DRC declared the outbreak in mid-May. It is the country's 17th Ebola outbreak and its largest to date.
The virus has crossed borders several times in recent months. Uganda recorded 20 cases, almost all among people who had travelled from the DRC, before being declared Ebola-free in August. Kenya reported two deaths and nine infections in October, the first Ebola cases recorded in the country.
In Nigeria, health authorities said two suspected cases in the northeast tested negative in two rounds of laboratory testing. Abuja reported its first imported case in October, the first in the country in more than a decade, and no deaths have been recorded. A single case involving a health worker who had returned from the DRC was reported in France in July.
There are no approved treatments or vaccines for the rare Bundibugyo strain. In recent weeks, clinical trials have begun with the Ervebo vaccine, which has proved effective against the more common Zaire strain of the virus.
The latest figures underline the scale of an outbreak that has spread beyond the DRC's borders, even as health authorities in neighbouring countries continue to screen and test suspected cases.